What blood tests are used to diagnose hyperthyroidism?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Blood Tests for Diagnosing Hyperthyroidism

The primary blood test for diagnosing hyperthyroidism is serum thyroid-stimulating hormone (TSH), followed by free thyroxine (FT4) and free triiodothyronine (FT3) measurements when TSH is abnormal. 1

First-Line Tests

  • Serum TSH is the most sensitive initial screening test for thyroid dysfunction, with a sensitivity of approximately 98% and specificity of 92% when used to confirm suspected thyroid disease 2
  • Low TSH levels (typically below 0.1 mIU/L) suggest hyperthyroidism 2
  • When TSH is abnormal, free thyroxine (FT4) and/or free triiodothyronine (FT3) measurements should be performed to differentiate between subclinical hyperthyroidism (normal FT4/FT3) and overt hyperthyroidism (elevated FT4/FT3) 3, 1
  • Multiple TSH measurements should be done over a 3-6 month interval to confirm abnormal findings, as TSH levels can vary by up to 50% day-to-day 2, 3

Additional Tests

  • TSH-receptor antibodies (TRAb) should be measured to confirm Graves' disease, which is the most common cause of hyperthyroidism (approximately 70% of cases) 4
  • Thyroid peroxidase antibodies (anti-TPO) may be helpful in identifying autoimmune thyroid disease 3, 4
  • Free T3 (FT3) measurement is particularly important for diagnosing hyperthyroidism, as some patients may have "T3-toxicosis" with normal T4 but elevated T3 levels 5

Interpretation of Results

  • Hyperthyroidism is biochemically confirmed by low TSH with elevated FT4 and/or FT3 4
  • Subclinical hyperthyroidism is characterized by low TSH with normal FT4 and FT3 levels 2, 4
  • Using a TSH cutoff value of 0.1 mIU/L provides a sensitivity of 98% and specificity of 98% for diagnosing hyperthyroidism 6

Important Considerations

  • TSH secretion can be affected by factors other than thyroid disorders, including:
    • Acute illness (can suppress TSH) 2
    • Medications (iodine, dopamine, glucocorticoids, octreotide, bexarotene) 2, 3
    • Pregnancy (particularly first trimester) 2
    • Adrenal insufficiency, anorexia nervosa, certain autoimmune diseases, and pituitary adenomas 2
  • TSH reference ranges vary among different laboratories (generally about 0.4 to 4.5 mIU/L) 2
  • TSH secretion varies among different subpopulations based on race/ethnicity, sex, and age 2

Common Pitfalls to Avoid

  • Relying on a single TSH value for diagnosis - serial measurements are essential due to day-to-day variability 2, 3
  • Ordering unnecessary tests - when TSH levels are in the reference range, additional tests like FT4, FT3, or thyroid antibodies rarely add value (except in patients with pituitary disease) 1
  • Overlooking the possibility of T3-toxicosis - some patients may have hyperthyroidism with normal T4 but elevated T3 levels 5
  • Failing to consider non-thyroidal factors that can affect TSH levels 2, 3
  • Overzealous use of thyroid ultrasound - it is not part of routine assessment of hyperthyroidism and can lead to identification of clinically unimportant thyroid nodules 1

Testing Algorithm

  1. Measure serum TSH as the initial screening test 1
  2. If TSH is low (< 0.1 mIU/L), measure FT4 and FT3 4, 1
  3. If FT4 and/or FT3 are elevated, overt hyperthyroidism is confirmed 4
  4. If FT4 and FT3 are normal with low TSH, subclinical hyperthyroidism is present 2
  5. Measure TSH-receptor antibodies to determine if Graves' disease is the cause 4
  6. Repeat TSH measurement after 3-6 months to confirm persistence of abnormal results 2, 3

References

Research

Managing thyroid disease in general practice.

The Medical journal of Australia, 2016

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnóstico y Manejo del Hipotiroidismo

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.